Viveve Medical Inc. [VIVE] Revenue clocked in at $4.50 million, down -55.36% YTD: What’s Next?

 Viveve Medical Inc. [VIVE] Revenue clocked in at $4.50 million, down -55.36% YTD: What’s Next?

Viveve Medical Inc. [NASDAQ: VIVE] jumped around 0.02 points on Tuesday, while shares priced at $0.56 at the close of the session, up 4.22%.

Viveve Medical Inc. stock is now -55.36% down from its year-to-date (YTD) trading value. VIVE Stock saw the intraday high of $0.5939 and lowest of $0.5322 per share. The company’s 52-week high price is 9.90, which means current price is +12.50% above from all time high which was touched on 02/19/20.

Compared to the average trading volume of 5.47M shares, VIVE reached a trading volume of 2916999 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Viveve Medical Inc. [VIVE]?

Stifel have made an estimate for Viveve Medical Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on July 23, 2019. The new note on the price target was released on July 23, 2019, representing the official price target for Viveve Medical Inc. stock.

The Average True Range (ATR) for Viveve Medical Inc. is set at 0.06, with the Price to Sales ratio for VIVE stock in the period of the last 12 months amounting to 1.95. The Price to Book ratio for the last quarter was 0.75, with the Price to Cash per share for the same quarter was set at 0.55.

How has VIVE stock performed recently?

Viveve Medical Inc. [VIVE] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.69. With this latest performance, VIVE shares gained by 0.99% in over the last four-week period, additionally sinking by -8.69% over the last 6 months – not to mention a drop of -90.37% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VIVE stock in for the last two-week period is set at 49.65, with the RSI for the last a single of trading hit 51.89, and the three-weeks RSI is set at 48.50 for Viveve Medical Inc. [VIVE]. The present Moving Average for the last 50 days of trading for this stock 0.5819, while it was recorded at 0.5491 for the last single week of trading, and 0.7487 for the last 200 days.

Viveve Medical Inc. [VIVE]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Viveve Medical Inc. [VIVE] shares currently have an operating margin of -455.87 and a Gross Margin at +15.47. Viveve Medical Inc.’s Net Margin is presently recorded at -647.57.

Return on Total Capital for VIVE is now -106.27, given the latest momentum, and Return on Invested Capital for the company is -151.67. Return on Equity for this stock declined to -396.83, with Return on Assets sitting at -115.23. When it comes to the capital structure of this company, Viveve Medical Inc. [VIVE] has a Total Debt to Total Equity ratio set at 26.53. Additionally, VIVE Total Debt to Total Capital is recorded at 20.97, with Total Debt to Total Assets ending up at 16.25. Long-Term Debt to Equity for the company is recorded at 24.91, with the Long-Term Debt to Total Capital now at 19.69.

Reflecting on the efficiency of the workforce at the company, Viveve Medical Inc. [VIVE] managed to generate an average of -$773,200 per employee. Receivables Turnover for the company is 1.80 with a Total Asset Turnover recorded at a value of 0.18.Viveve Medical Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.50 and a Current Ratio set at 3.50.

Earnings analysis for Viveve Medical Inc. [VIVE]

With the latest financial reports released by the company, Viveve Medical Inc. posted -13.51/share EPS, while the average EPS was predicted by analysts to be reported at -16/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 15.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VIVE. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Viveve Medical Inc. go to 20.00%.

Insider trade positions for Viveve Medical Inc. [VIVE]

There are presently around $0 million, or 2.70% of VIVE stock, in the hands of institutional investors. The top three institutional holders of VIVE stocks are: BLACKROCK INC. with ownership of 257,947, which is approximately 3842.335% of the company’s market cap and around 0.13% of the total institutional ownership; JANE STREET GROUP, LLC, holding 55,671 shares of the stock with an approximate value of $31000.0 in VIVE stocks shares; and UBS GROUP AG, currently with $20000.0 in VIVE stock with ownership of nearly 401.806% of the company’s market capitalization.

Positions in Viveve Medical Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 5 institutional holders increased their position in Viveve Medical Inc. [NASDAQ:VIVE] by around 361,770 shares. Additionally, 5 investors decreased positions by around 99,220 shares, while 5 investors held positions by with 72,801 shares. The mentioned changes placed institutional holdings at 388,189 shares, according to the latest SEC report filing. VIVE stock had 2 new institutional investments in for a total of 81,638 shares, while 5 institutional investors sold positions of 99,220 shares during the same period.

An article written by Misty Lee on dbtnews.com

Related post